NCT01913132 PICO Above Incisions After Vascular Surgery
| NCT ID | NCT01913132 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Stefan Acosta |
| Condition | Wound |
| Study Type | INTERVENTIONAL |
| Enrollment | 644 participants |
| Start Date | 2013-11 |
| Primary Completion | 2026-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 644 participants in total. It began in 2013-11 with a primary completion date of 2026-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The wound infection rate in the groin after vascular surgery has been denoted to be high since the wound surveillance register started in 2005. The current wound infection rate based on a validation study was 22.9% (24/105 patients with groin incision(s) between 1 March to 30 June in 2012). This randomized controlled trial aims to evaluate if negative pressure wound therapy on closed inguinal incisions (INPWT) after vascular surgical procedures can reduce the risk for surgical site infections and other wound complications.
Eligibility Criteria
Inclusion Criteria: * Patients 18 years of age and above * Elective vascular surgery * Inguinal incision (transverse or longitudinal) * Capable of understanding the study information and giving written informed consent Exclusion Criteria: * Emergency surgery * Ongoing infection in inguinal area
Contact & Investigator
Stefan Acosta, MD PhD
PRINCIPAL INVESTIGATOR
Vascular Centre, Malmö, Skåne University Hospital
Frequently Asked Questions
Who can join the NCT01913132 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Wound. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT01913132 currently recruiting?
Yes, NCT01913132 is actively recruiting participants. Contact the research team at stefan.acosta@med.lu.se for enrollment information.
Where is the NCT01913132 trial being conducted?
This trial is being conducted at Malmö, Sweden.
Who is sponsoring the NCT01913132 clinical trial?
NCT01913132 is sponsored by Stefan Acosta. The principal investigator is Stefan Acosta, MD PhD at Vascular Centre, Malmö, Skåne University Hospital. The trial plans to enroll 644 participants.